Gaming Console Home-Based Exercise for Adults With Cystic Fibrosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02277860|
Recruitment Status : Completed
First Posted : October 29, 2014
Last Update Posted : March 12, 2018
|Condition or disease||Intervention/treatment||Phase|
|Cystic Fibrosis||Behavioral: Exercise||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||11 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Gaming Console Home-Based Exercise for Adults With Cystic Fibrosis|
|Study Start Date :||May 2015|
|Actual Primary Completion Date :||December 2017|
|Actual Study Completion Date :||December 2017|
Aerobic and strength training using the Wii Fit Plus for ≥ 30 min, ≥3 days/week, for 12 weeks, at a moderate intensity (Borg CR10 3-5).
Aerobic and strength training using the Wii Fit for ≥ 30 min, ≥3 days/week, for 12 weeks, at a moderate intensity (Borg CR10 3-5).
- Peak oxygen consumption (VO2 peak) [ Time Frame: 12 and 24 weeks ]Measure of aerobic physical fitness
- Nasal potential difference (NPD) [ Time Frame: 12 weeks ]Measure of respiratory/airway ion transport
- Cystic Fibrosis Questionnaire-Revised (CFQ-R)) [ Time Frame: 12 and 24 weeks ]Health-related quality of life questionnaire (especially respiratory-related symptoms)
- Habitual physical activity level [ Time Frame: 12 and 24 weeks ]Accelerometer-based measure of frequency, intensity and duration of bouts of physical activity while user is wearing device.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02277860
|United States, Alabama|
|University of Alabama at Birmingham|
|Birmingham, Alabama, United States, 35294-1212|
|Principal Investigator:||John D Lowman, PhD||University of Alabama at Birmingham|